Rhinoconjunctivitis
📧 Sign up to get email alerts when something new happens for Rhinoconjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of sublingual immunotherapy (SLIT) for rhinitis and rhinoconjunctivitis due to dus…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM) [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled trial to assess the efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL subcutaneous immu…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen [Phase 3]
Phase 3 trial evaluating PQ Grass for grass pollen–induced seasonal allergic rhinitis and rhinoconjunctivitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy [Phase 2]
Phase 2 dose-finding trial update for grass pollen allergy showing results in rhinitis and rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy [Phase 2]
Phase 2 dose-finding trial for a mite allergy treatment in rhinitis and rhinoconjunctivitis is ongoing; status unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice
A completed clinical trial evaluated the tolerability and safety of Allergovac Poliplus in polysensitized patients with allergic rhinitis or…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Depigoid Birch 5000 Longterm Study in Adults and Adolescents [Phase 3]
Phase 3 long-term study update for Depigoid Birch 5000 in adults and adolescents with birch pollen allergy and related rhinitis/sensitoconju…
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma [Phase 2]
Phase 2 trial evaluating safety, tolerability and efficacy of a depigmented modified allergen extract from two mites in subjects with allerg…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Phase III Cat-PAD Study [Phase 3]
Circassia's Phase III Cat-PAD trial for rhinoconjunctivitis has completed and its results were posted on May 14, 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Paediatric Safety Study in Cat-PAD [Phase 2]
A Phase 2 pediatric safety study of Cat-PAD for rhinoconjunctivitis has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen [Phase 3]
Phase 3 trial update for subcutaneous immunotherapy targeting hypersensitivity to olive pollen (Olea europaea) in patients with rhinitis/rhi…
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea [Phase 1]
Phase 1 trial of depot-formulation subcutaneous immunotherapy for rhinoconjunctivitis due to Olea europaea (olive tree) pollen has completed…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica [Phase 1]
Phase 1 multicenter open-label trial evaluating subcutaneous immunotherapy for rhinoconjunctivitis in Parietaria judaica-sensitized patients…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense [Phase 1]
Phase 1 trial update for subcutaneous immunotherapy (SCIT) in patients with rhinoconjunctivitis sensitized to olive and Timothy grass; the s…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Phase 3]
Phase 3 trial update for SCH 900237/MK-8237 in children and adults with perennial and nonseasonal allergic rhinitis/rhinoconjunctivitis; stu…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) [Phase 2]
Phase 2 dose-ranging study evaluating the safety and effectiveness of MK-8237 for house dust mite–induced allergic rhinitis/rhinoconjunctivi…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Ragweed-SPIRE Follow-On Study
Circassia Limited reports that the Ragweed-SPIRE follow-on clinical trial has completed. The study targeted rhinoconjunctivitis and ragweed …
-
CLINICAL_TRIALS research · 2015-04-08Clinical Trial Update: Grass Observational Study
Circassia Limited completed an observational study on grass pollen allergy presenting with rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: ToleroMune Grass Follow on Study
This update indicates that the ToleroMune Grass follow-on clinical trial for grass pollen-induced rhinoconjunctivitis/rgrass allergy has com…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma [Phase 3]
A Phase 3 pivotal trial of recombinant Timothy grass allergen (rPhleum) in adults and adolescents with rhinoconjunctivitis with or without c…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: ToleroMune House Dust Mite (HDM) Tolerability Study [Phase 2]
Phase 2 tolerability trial of ToleroMune for rhinoconjunctivitis (HDM) has completed; this update highlights tolerability findings from the …
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) [Phase 2]
Phase 2 safety study of a ragweed pollen immunotherapy tablet in adults aged 50 and older (Study P06081) has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: An Optional Investigation of Biomarkers of Efficacy
Circassia Limited reports an optional biomarker study for efficacy in rhinoconjunctivitis; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: House Dust Mite Observational Study
Circassia Limited completed an observational clinical trial evaluating house dust mite exposure related to rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]
Phase 2 dose-finding study evaluating four doses of Depigoid Phleum in patients with allergic rhinitis/rhinoconjunctivitis, with or without …